Atrial fibrillation (AF) is a common arrhythmia and gastroesophageal reflux disease (GERD) is popular in Japan. The two common diseases share several predisposing factors such as lifestyle and senescence, and inflammation and oxidative stress play an important role in their development and progression. Incidental cases of AF treated successfully by proton pump inhibitor (PPI) applied for coexisting GERD have been sporadically reported. An increasing evidence indicates that GERD induces the initiation and the perpetuation of AF. This is caused by the autonomic nerve influence, mechanical compression, and propagation of local inflammation due to proximity of left atrium (LA) and lower esophagus. Meanwhile, AF also develops GERD by mechanical and inflammatory actions of LA characterized by remodeling and inflammation. The robust association of AF with GERD is not limited to their natural interaction, i.e., pharmacological or nonpharmacological treatment of AF is reported to aggravate GERD. Many cardiac drugs (anticoagulants, calcium antagonists, and nitrates) induce esophageal mucosal damage and lower esophageal sphincter relaxation promoting acid reflux. These drugs are frequently prescribed in patients with AF for stroke prevention, rate control, and for coexisting coronary heart disease.
impaired quality of life and various comorbidities including cardiogenic stroke and heart failure. Therefore, primary AF prevention in the elderly is drawing an increasing attention in the super-aged society of Japan from the viewpoint of health care and economic burden.
Gastroesophageal reflux disease (GERD) is the most common gastroesophageal disorder and increasing in developed countries including Japan. This is due to the inappropriate lifestyle in the middle ages such as excess food consumption, 5 obesity, 6 sleep apnea 7 and hiatus hernia in the elderly. 8 Because susceptible age for AF overlaps that for GERD, causal relationship between AF and GERD has been suggested. Since we encountered a case of paroxysmal AF treated successfully by proton pump inhibitor (PPI) administered for coexisting GERD, 9 the relationship between AF and GERD has been investigated in our laboratory. [10] [11] [12] [13] In this article, we review the potential linkage of these two common diseases including our investigations and highlight that this association is not coincidental, i.e., the two common diseases show natural linkage and the treatments of AF affects GERD and vice versa irrespective of whether the treatment is pharmacological or non-pharmacological. Herein, AF means non-valvular AF, unless otherwise mentioned in this article.
| GERD AS A CAUSE OF AF
Several epidemiological studies have clarified GERD playing a pivotal role triggering and promoting AF. Huang et al 14 Causal relationship between AF and GERD is based potentially on the three main factors, such as (a) autonomic nerve activation, (b) mechanical irritation of esophagus to the left atrium (LA) due to anatomical proximity, and (c) esophageal inflammation inducing the development of local pericarditis or atrial myocarditis.
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| Autonomic influence
The episodes of atrial arrhythmia are sometimes induced by swallowing and food passage through esophagus. 
| Inflammatory process
In recent years, it is acceptable that local or systemic inflammation is a risk factor for AF. Inflammatory process is known to trigger newonset of AF, sustain AF and allow postablative AF recurrence. [32] [33] [34] [35] AF without any structural heart diseases is termed lone AF. However, atrial myocarditis is confirmed in 66% of atrial biopsy specimens in patients with lone AF. 36 As compared with conventional risk , and prognosis of AF. 43 AF and GERD may be complementary partners sharing common inflammatory mediators, which maintain and progress these two diseases. These observational studies indicate that the therapeutic effects of PPI on the paroxysmal AF are mediated by cardiogastric interaction triggered by acid reflux. In addition, PPI has multimodal effects beyond acid suppression mediated by inhibiting proton pump (K + -H + ATP ase ) in gastric mucosa. 47 Emerging evidence suggests that PPI shows antioxidant and anti-inflammatory effects that also potentiate acid inhibition. PPI is reported to suppress stress-induced production of hydroxyradical ( − OH) in vitro. 48, 49 Further, there have been several reports concerning anti-inflammatory actions of PPI against leukocytes, epithelial, and endothelial cells, which are mediated in part by modulating tissue and intracellular pH homeostasis. 47 The oxidative and inflammatory process is considered to play an important role in the initiation and progression of AF. [32] [33] [34] [35] Gastric
| Effects of PPI on AF
Correlation between lower esophageal pH and low/high frequency component ratio (LF/HF) obtained by pH monitoring and power spectrum analysis of heart rate variability in patients with arrhythmia and gastroesophageal reflux disease (n = 18). Two thirds of these patients showed positive correlation indicating that acid reflux elevates vagal nerve activity (A), whereas one third of patients demonstrated negative correlation meaning acid-induced sympathetic activation (B) 24 MARUYAMA ET AL. with lower esophagus, 52, 56 where LA inflammation may propagate to esophageal adventitia leading to the esophageal mucosal inflammation. [17] [18] [19] 37 The potentially involved mechanisms for natural linkage of AF and GERD are illustrated in Figure 4 . 19 However, conventional treatment of AF per se may have a potential risk for GERD. Therapeutic strategy of AF includes pharmacological and nonpharmacological treatment. AF treatment tends ironically to develop and aggravate GERD, and therapeutic linkage of AF and GERD may be stronger than the natural linkage of the two common diseases.
| Pharmacological treatment
Many cardiac and noncardiac drugs are involved in the development of GERD. Although noncardiac drugs such as nonsteroidal antiinflammatory drugs, anticholinergic drugs, and β agonistic drugs are reported to cause GERD, 57 we would like to focus on common cardiac drugs likely causing GERD. Because GERD is a representative disease inducing noncardiac chest pain (NCCP) and cardiac drugs may be prescribed frequently to the patients complaining NCCP in general practice. Nakaji et al 10 investigated the influence of the common cardiac drugs on the development of GERD by multicenter questionnaire survey. They concluded that both calcium channel blockers and warfarin are independent risk factors for symptomatic GERD. Although calcium channel blockers and nitrates may be effective to NCCP underlying spastic esophageal motility, 58 these drugs cause lower esophageal sphincter relaxation, impair the esophageal clearance, and allow acid reflux. 57 Calcium channel blockers are used widely for rate control in patients with AF, and so are nitrates for coexisting coronary heart disease.
Current problem with this concern is the worldwide use of direct oral anticoagulants (DOAC) for stroke prevention in patients with AF. Dabigatran, a direct thrombin inhibitor, is the first DOAC commercialized in the world. This DOAC is known to cause dyspepsia in the RE-LY study, an international phase III trial demonstrating the noninferiority for efficacy (i.e., stroke prevention) and the superiority for safety (i.e., major bleeding) of dabigatran compared with conventional vitamin K antagonist (VKA: warfarin) under keeping steady time in therapeutic range. In this trial, dabigatran-induced upper gastrointestinal nonbleeding adverse effect was 16.9% compared with 9.4% in controls (warfarin group) showing relative risk of 1.81 (1.66-1.97 in 95% CI, P < 0.001). 59 The most frequent adverse event was GERD compared with simple dyspepsia or dysmotility, and the symptoms were dose-independent and mostly mild to moderate in severity. Dabigatran-induced esophagitis was found to be about 20% of F I G U R E 3 Kaplan-Meier curves of the cumulative incidence of gastroesophageal reflux disease (GERD) in patients with and without atrial fibrillation (AF). There is a significant difference between the two curves (P = 0.008 in log-rank test) 55 dabigatran use in Japanese endoscopic study. 60 Because patients with AF are managed with long-term anticoagulants either DOAC or VKA, these gastroesophageal findings should guide management of AF patients.
| Nonpharmacological treatment
Pulmonary vein isolation (PVI) is a standard ablation technique for symptomatic and drug-refractory AF. To date, many kinds of power energy are available such as irrigating radiofrequency (RF) energy, hot balloon, cryo-balloon, laser balloon, and so on. Whatever power modality used, ablation technique is associated sometimes with the complication of esophageal lesions leading to the lethal atrioesophageal fistula (AEF). 61 The esophageal lesion is considered as thermal injury induced by ablation procedure and ranging in severity from erythema, esophagitis, ulceration, necrosis, and finally to fistula formation. 62 In parallel to such thermal injury, significant acid reflux is documented after the RF catheter ablation targeting AF. Martinek et al 63 demonstrated significant acid reflux in nearly 20% of patients with AF after RF ablation by using leadless lower esophageal pH monitoring. Because acid reflux did not correlate to the baseline characteristics, sedation, ablation approach, and total ablating energy, they speculated that the reflux might be caused simply by the prolonged supine position of the patients during procedure.
Atrioesophageal fistula is a catastrophic complication of ablation for AF with an incidence of 0.03%-1.5% per year. 64 Although conflicting results with respect to the genesis of AEF were reported, 65 esophageal ulcer caused by thermal injury is considered as a precursor lesion of AEF, and acid reflux is thought to aggravate ulceration to the fistula. 63 This "two hit theory" for the development of AEF is supported by the following results, i.e., (a) thermal esophageal lesion is associated with acid reflux as a consequence of periesophageal vagal nerve injury, 66 (b) prophylactic use of PPI is highly recom- The potential association of AF with GERD is supported by several predisposing factors shared by these two common diseases.
Anatomical vicinity, mechanical contact, autonomic reflex, and inflammatory biomarkers are involved in this association. However, many large-sample investigations are retrospective observational studies or case-control studies using health insurance dataset. [14] [15] [16] 55 The diagnosis of AF is based on the International Disease Classification, and asymptomatic, paroxysmal AF may have been underestimated in epidemiological studies. Many paroxysms of AF are usually asymptomatic, and hence accurate diagnosis of AF should be based on the insertable loop recorder or the implantable device interrogation. 70 In this sense, Odashiro et al 13 investigated the prevalence of GERD in arrhythmic patients and the effects of adjunctive PPI administration on the comorbid AF. They showed (a) that AF was most prevalent in arrhythmic patients associated with GERD and (b)
that temporal correlation between AF and GERD symptoms was improved simultaneously by the oral administration of PPI. However, they failed to demonstrate the therapeutic effects of PPI on the number, the maximum duration, and the total duration of paroxysms of AF by the interrogation of permanent pacemaker implanted for sick sinus syndrome. 
| CORRELATION OF AF AND SYSTEMIC
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